InvestorsHub Logo
icon url

ziploc_1

01/04/22 7:00 PM

#365362 RE: ziploc_1 #365358

Insurance companies will now claim that Amarin is acting against patients' health...Amarin must counter this claim by saying their goal is to make Vascepa more affordable for more patients' CVD...and, by lowering Insurance companies' price tiers for Vascepa, Amarin is making Vascepa more affordable for more patients.